Jody Hutson
Family Medicine · Seneca, SCNPI 1669488755
Payments from drug & device makers
Across 320 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$722
- AstraZeneca$623
- GSK$530
- AbbVie$338
- Pfizer$276
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,043100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 69 | $1,038 |
| Lilly USA, LLC | 51 | $722 |
| AstraZeneca | 31 | $623 |
| GSK | 38 | $530 |
| AbbVie | 18 | $338 |
| Pfizer | 18 | $276 |
| Bayer | 11 | $181 |
| Exact Sciences | 8 | $117 |
| Novartis | 7 | $107 |
| Sanofi-aventis U.S. LLC | 6 | $103 |
| Boehringer Ingelheim | 7 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Johnson & Johnson | 6 | $90 |
| Dexcom, Inc. | 5 | $83 |
| Abbott | 5 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| Neurocrine Biosciences, Inc. | 3 | $56 |
| Merck | 3 | $55 |
| Astellas Pharma US Inc | 3 | $48 |
| Daiichi Sankyo Inc. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Nestle Healthcare Nutrition Inc. | 2 | $33 |
| Amgen | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Eisai Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$5,043 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 169 | $167,599 |
| JardianceEmpagliflozin | 82 | $102,778 |
| OzempicSemaglutide | 69 | $99,490 |
| MounjaroTirzepatide | 67 | $85,980 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 92 | $63,355 |
| LinzessLinaclotide | 37 | $37,816 |
| TrulicityDulaglutide | 28 | $32,362 |
| Diclofenac Sodium | 130 | $31,144 |
| RybelsusSemaglutide | 21 | $29,190 |
| FarxigaDapagliflozin Propanediol | 26 | $27,606 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $20,638 |
| EntrestoSacubitril/Valsartan | 19 | $19,898 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $19,814 |
| JanuviaSitagliptin Phosphate | 21 | $14,742 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $12,609 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $276 | $167,599169 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Stiolto Respimat | $97 | $133,065109 claims |
| Novo NordiskOzempic, Rybelsus | $1,038 | $128,68090 claims |
| Lilly USA, LLCMounjaro, Trulicity | $722 | $118,34195 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $530 | $75,964114 claims |
| AbbVieLinzess | $338 | $37,81637 claims |
| AstraZenecaFarxiga, Symbicort | $623 | $33,25943 claims |
| MerckJanuvia, Janumet Xr | $55 | $26,99935 claims |
| NovartisEntresto | $107 | $19,89819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Seneca
- Thomas EvansSeneca$60K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.